320 related articles for article (PubMed ID: 27135827)
1. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
[TBL] [Abstract][Full Text] [Related]
2. The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.
Semba T; Nishimura M; Nishimura S; Ohara O; Ishige T; Ohno S; Nonaka K; Sogawa K; Satoh M; Sawai S; Matsushita K; Imazeki F; Yokosuka O; Nomura F
BMC Gastroenterol; 2013 Jul; 13():120. PubMed ID: 23875831
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
6. Role of MicroRNAs in NAFLD/NASH.
Szabo G; Csak T
Dig Dis Sci; 2016 May; 61(5):1314-24. PubMed ID: 26769057
[TBL] [Abstract][Full Text] [Related]
7. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.
Luk JM; Burchard J; Zhang C; Liu AM; Wong KF; Shek FH; Lee NP; Fan ST; Poon RT; Ivanovska I; Philippar U; Cleary MA; Buser CA; Shaw PM; Lee CN; Tenen DG; Dai H; Mao M
J Biol Chem; 2011 Sep; 286(35):30706-30713. PubMed ID: 21737452
[TBL] [Abstract][Full Text] [Related]
8. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
Johnson K; Leary PJ; Govaere O; Barter MJ; Charlton SH; Cockell SJ; Tiniakos D; Zatorska M; Bedossa P; Brosnan MJ; Cobbold JF; Ekstedt M; Aithal GP; Clément K; Schattenberg JM; Boursier J; Ratziu V; Bugianesi E; Anstee QM; Daly AK; ;
JHEP Rep; 2022 Feb; 4(2):100409. PubMed ID: 35072021
[TBL] [Abstract][Full Text] [Related]
9. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V
Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD.
Estep JM; Goodman Z; Sharma H; Younossi E; Elarainy H; Baranova A; Younossi Z
Liver Int; 2015 Apr; 35(4):1367-72. PubMed ID: 24684403
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR-4/FoxO3 pathway.
Samy AM; Kandeil MA; Sabry D; Abdel-Ghany AA; Mahmoud MO
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300631. PubMed ID: 38574101
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.
Hennig EE; Mikula M; Goryca K; Paziewska A; Ledwon J; Nesteruk M; Woszczynski M; Walewska-Zielecka B; Pysniak K; Ostrowski J
J Cell Mol Med; 2014 Sep; 18(9):1762-72. PubMed ID: 24913135
[TBL] [Abstract][Full Text] [Related]
13. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
[TBL] [Abstract][Full Text] [Related]
14. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.
Gardiner E; Beveridge NJ; Wu JQ; Carr V; Scott RJ; Tooney PA; Cairns MJ
Mol Psychiatry; 2012 Jul; 17(8):827-40. PubMed ID: 21727898
[TBL] [Abstract][Full Text] [Related]
15. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP
Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and Nonalcoholic Steatohepatitis: A Review.
Morishita A; Oura K; Tadokoro T; Fujita K; Tani J; Kobara H; Ono M; Himoto T; Masaki T
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833930
[TBL] [Abstract][Full Text] [Related]
18. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
19. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status.
Li S; Chen X; Zhang H; Liang X; Xiang Y; Yu C; Zen K; Li Y; Zhang CY
J Lipid Res; 2009 Sep; 50(9):1756-65. PubMed ID: 19372595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
